https://doi.org/10.4081/monaldi.2021.1828

Intermittent abdominal pressure ventilation: feasibility and efficacy in neuromuscular disease. A case report

Vol. 91 No. 4 (2021)
Submitted: March 1, 2021
Accepted: May 30, 2021
Published: August 3, 2021
Neuromuscular disease, daytime ventilation, non-invasive ventilation
Abstract Views: 1320
PDF: 506
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Cristina Puricelli
cpuricelli@dongnocchi.it
https://orcid.org/0000-0003-0706-4114
IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi, Milan, Italy.
Eleonora Volpato
https://orcid.org/0000-0003-0266-6386
IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi; Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy.
Salvatore Sciurello
https://orcid.org/0000-0002-2530-9069
IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi, Milan, Italy.
Antonello Nicolini
Respiratory Diseases Unit, General Hospital, Sestri Levante, Genoa, Italy.
Paolo Banfi
https://orcid.org/0000-0001-8162-0751
IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi, Milan, Italy.

The standard treatment for patients with neuromuscular respiratory failure is non-invasive ventilation (NIV) as non-invasive ventilation support-setting (NVS). NVS is administered through a nasal or face mask and/or mouthpiece with the potential to cause nasal ulcers, discomfort, and/or aesthetic issues, resulting in poor compliance. We reported the observation of a 45-year-old woman with limb-girdle muscular dystrophy (LGMD), secondary to Dysferlin deficiency, who was on NVS since 2017 for nocturnal hypoventilation. In 2018, despite nocturnal ventilation, due to weight gain and daytime hypoventilation, a nasal mask was introduced. We initiated daytime intermittent abdominal pressure ventilation (IAPV) to mitigate cosmetic problems, improving in pO2 and decreasing in pCO2 versus baseline (52>84 mmHg, 46>33 mmHg respectively) at 6 (85 mmHg, 42 mmHg) and 18 months (93 mmHg, 38 mmHg), respectively. IAPV was effective, safe, and well-tolerated in our patients who did not tolerate standard daytime NVS with the known interface.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Hess DR. Noninvasive ventilation in neuromuscular disease: equipment and application. Respir Care 2006;51:896-911; discussion 911-2.
Fiorentino G, Annunziata A, Gaeta AM, et al. Continuous noninvasive ventilation for respiratory failure in patients with amyotrophic lateral sclerosis: current perspectives. Degener Neurol Neuromuscul Dis 2018;8:55-61. DOI: https://doi.org/10.2147/DNND.S170771
Bach JR, Alba AS. Intermittent abdominal pressure ventilator in a regimen of noninvasive ventilatory support. Chest 1991;99:630-6. DOI: https://doi.org/10.1378/chest.99.3.630
Cardus D, Vallbona C, Spencer WA. Effects of three kinds of artificial respirators on the pulmonary ventilation and arterial blood of patients with chronic respiratory insufficiency. Dis Chest 1966;50:297-306. DOI: https://doi.org/10.1378/chest.50.3.297
Windisch W, Dreher M, Geiseler J, et al. Guidelines for non-invasive and invasive home mechanical ventilation for treatment of chronic respiratory failure - Update 2017. Pneumologie 2017;71:722-95.
Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017;50: 1602426. DOI: https://doi.org/10.1183/13993003.02426-2016
Yang GF, Alba A, Lee M, Khan A. Pneumobelt for sleep in the ventilator user: clinical experience. Arch Phys Med Rehabil 1989;70:707-11.
Seliger GM, Zackson H, Nichols L, et al. Neurological improvement following respiratory support in syringomyelia: case report. Paraplegia 1990;28:526-8. DOI: https://doi.org/10.1038/sc.1990.70
Banfi PI, Volpato E, Bach JR. Efficacy of new intermittent abdominal pressure ventilator for post-ischemic cervical myelopathy ventilatory insufficiency. Multidiscip Respir Med 2019;14:4. DOI: https://doi.org/10.4081/mrm.2019.7
De Mattia E, Iatomasi M, Garabelli B, et al. Use of the intermittent abdominal pressure ventilation to guarantee speech in a tracheostomized amyotrophic lateral sclerosis patient. Rev Port Pneumol (2006) 2017; 23236-9.
Hill NS. Clinical applications of body ventilators. Chest 1986;90:897-905. DOI: https://doi.org/10.1378/chest.90.6.897
Balestroni G, Bertolotti G. [EuroQol-5D (EQ-5D): an instrument for measuring the quality of life].[Article in Italian]. Monaldi Arch Chest Dis 2012;78:155-9.
No authors listed. The world health organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;46:1569-85. DOI: https://doi.org/10.1016/S0277-9536(98)00009-4

Rights

The authors have obtained the written informed consent of the patient mentioned in the article to collect her data and share her photo. The corresponding author is in possession of the written informed consent.

How to Cite

Puricelli, Cristina, Eleonora Volpato, Salvatore Sciurello, Antonello Nicolini, and Paolo Banfi. 2021. “Intermittent Abdominal Pressure Ventilation: Feasibility and Efficacy in Neuromuscular Disease. A Case Report”. Monaldi Archives for Chest Disease 91 (4). https://doi.org/10.4081/monaldi.2021.1828.
Copyright (c) 2021 The Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.